OTC · CLVR
Healthcare · Drug Manufacturers - Specialty & Generic
$0.00
Up+$0.00 (+0.00%)
Updated Sep 13, 2026, 1:42 AM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 3 trading sessions · Daily adjusted prices
CLVR closed at $0.00 after 3 trading sessions.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 8, 2026 | $0.0002 | $0.0002 | $0.0002 | $0.0002 | 403 |
| Aug 24, 2026 | $0.0002 | $0.0002 | $0.0002 | $0.0002 | 426 |
| Aug 18, 2026 | $0.00 | $0.00 | $0.00 | $0.00 | 500 |
The latest Smart Investors Daily articles mentioning CLVR.
CLVR research
Company profile and research snapshot.
CLEVER LEAVES HLDGS INC
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 6, 2023 | Canaccord Genuity | Hold | — |
| Nov 11, 2022 | Canaccord Genuity | Hold | — |
| Nov 10, 2022 | Cantor Fitzgerald | Overweight | — |
| Aug 12, 2022 | Cantor Fitzgerald | Overweight | — |
| Aug 1, 2022 | Cantor Fitzgerald | Overweight | — |
No generated briefing is available yet.
Benzinga · Nov 8, 2024
Industry experts, including Josh Kesselman and Javier Hasse, will discuss cannabis branding and the evolving Latin American cannabis markets at the upcoming MJBizCon event.
GlobeNewswire Inc. · Apr 26, 2024
TOCANCIPÁ, Colombia, April 26, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, today announced that its Board of Directors (the “Board”) determined to voluntarily delist its common shares, without par value (the “common shares”) and warrants, each exercisable for 1/30th common share at an exercise price of $11.50 (the “Warrants” and together with the common shares, the “Securities”) from The Nasdaq Stock Market LLC (“Nasdaq”) and deregister its Securities in order to terminate and suspend its reporting obligations under the Securities and Exchange Act of 1934, as amended (the “Exchange Act”).
GlobeNewswire Inc. · Apr 1, 2024
- 2023 Revenue Increased 6% Year-Over-Year, with a 39% Increase in Full-Year Cannabinoid Revenue -
GlobeNewswire Inc. · Feb 13, 2024
TOCANCIPÁ, Colombia, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a global medicinal cannabis company, announced today that through its partnership with award-winning Dutch seed bank, Paradise Seeds (“Paradise”), to develop and register high performance cannabis cultivars in Colombia, Clever Leaves will have exclusive license to cultivate some of these genetics, while Paradise will make other cultivars available to third parties for cultivation across Colombia and Latin America. The two companies have already begun rigorous selection, phenotyping, and agronomic trials of several Paradise varieties at Clever Leaves’ facility in order to register market-leading cultivars for production and commercialization.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning CLVR.
No results
No recent SID articles mention CLVR.
